Tatva Chintan Pharma Chem Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/iqe3x2f9v50r5odo289onbnp.pdf

Key Takeaways


SDA: The Margin Reset & Recovery

Chintan Shah: "See what has happened actually in this last 1.5 months, the price of two specific SDAs, which have prominent sales among all the product category, the key raw material prices started coming down from $19, today, it is being quoted at $13.5. So of course, the customer will also expect you to reduce the price based on the pricing formula that you have."

The FY24 Growth Bridge: Late-Stage Catalysts


Margins: The Path Back to 18–20%

Chintan Shah: "I can assure you probably this was our last surprise."

Electrolyte Salts: The Next SDA?


Pricing & Raw Material Dynamics

Chintan Shah: "Both the situations are not good for manufacturers. I can tell you that. We have passed through both the cycles. And when it's an increasing pricing cycle, customer wants you to hold the prices till you have executed all their pending orders. And when it's a falling pricing market, then customer wants a price change to happen from tomorrow. So you are always in trouble in both."

Capacity & Capex: Building for FY26


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth20–30% YoY growth (management calls this "definitely a conservative forecast")FY24
EBITDA margin18–20% rangeFY24
EBITDA margin20–22% ("safer number")FY25
SDA inventory clearanceAll excess SDA inventory consumed; last dispatch from old stock by end of May 2023May 2023
Electrolyte customer resumptionLarge customer on hold for ~4 months to restart suppliesJune 2023
Continuous flow pilot fixTeething troubles resolved, smooth pilot trial runningEnd of May 2023
Continuous flow product trial dispatchPlant-scale trial material dispatched for second productEnd of August 2023
Flame retardant demand normalcyCustomers expect decent demand modeAugust–September 2023
Four SDAs with new customerCommercialization at large volumesNovember 2023
Newly approved productCommercial orders beginNovember–December 2023
New capex executionPlanning and design started; execution beginsEnd of December 2023
Continuous flow product commercial supplySecond product commercial supplies beginJanuary 2024
Largest intermediate productCommercialization, subject to plant-scale trial approval (dispatch by July/August 2023)January 2024
Dahej facility utilizationRamp to 75–80% occupancyFrom January 2024
Electrolyte plant-scale trialTrial order executed for pilot-approved customerBy October 2023
PASC segment growth~75–80% growth from FY23 basis at current pricingFY25
Flame retardants revenue~₹200 crores (management notes this is difficult to forecast due to raw material price volatility)FY25
Electrolyte salts revenue inflectionReal sales growth begins to become a decent part of overall revenueFY25
Capacity absorption~85% occupancy, triggering need for next capex cycleFY26

Key Metrics

MetricQ4 FY23
Revenue from operations₹124.5 cr, +26% YoY
Full year FY23 revenue₹4,236 cr, -2% YoY
EBITDA₹16.3 cr, -26% YoY
EBITDA margin13%, vs 22% in Q4 FY22
PAT₹17 cr, -3% YoY
PAT margin14%, vs 18% in Q4 FY22
FY24 revenue growth guidance20%–30%
FY24 EBITDA margin guidance18%–20%
PTC segment revenue₹37.8 cr, full year ₹143.2 cr, +46% YoY
Electrolyte Salts segment revenue₹0.9 cr, full year ₹16.5 cr, +191% YoY
PASC segment revenue₹29.9 cr, full year ₹133.5 cr, +31% YoY
SDA segment revenue₹54.9 cr, full year ₹127.7 cr, -43% YoY
Exports₹304.2 cr (FY23), 72% of revenue
Consolidated inventory₹132.5 cr as on Mar 23, down from ₹188.7 cr as on Sep 22
Working capital limit utilization71% of ₹220 cr sanctioned limits
IPO proceeds utilized₹195.3 cr of ₹207.28 cr, 94% utilized
New Dahej facility expected FY24 utilization30%–35%
Flame retardants FY24 revenue expectation₹40–50 cr
SDA FY24 revenue expectationpotentially hit same number as FY22 (approx ₹226 cr)
Electrolyte salts FY24 growth expectation~100%
PASC FY25 growth expectation75%–80% over FY23
FY25 EBITDA margin expectation20%–22%
Effective tax rate FY2417%–18%, assuming Dahej and Ankleshwar profit ratio of 2:1